Is Moonrock Molly becoming a prevalent drug abuse problem?

Moonrock Molly has become a drug that has been found in almost every state in the U.S. It’s a multi-billion dollar business. In addition to the U.S., Moonrock Molly is a growing drug problem in Australia, New Zealand and Europe.

There is evidence that this drug has become a major drug abuse problem for the U.S.. Investigations by the RCMP and the Office of National Drug Control Policy in the U.S. are revealing that Canada may be one of the main suppliers of MDMA.

President Barack Obama’s Drug Czar reveals that pills similar to MDMA, that look like candy or children’s vitamins that were apprehended near U.S. schools, were linked back to Canadian sources. The U.S. Office of National Moonrock Molly Drug Control Policy report states that “Marijuana and ecstasy remain the most significant Canadian drug threats to the United States.”

In March 2012, drugs that contain MDMA were elevated as a Schedule I drug under Bill C-10. Meaning that in Canada, drugs such as Moonrock Molly are now classified along with heroin and cocaine and are more severely punished than possession of other drugs listed in other schedules.

Between July 2011 and March 2012, there were 19 MDMA-related deaths in BC and 12 in Alberta, as per RCMP’s Just the Facts. BC is being identified as North America’s main producer for ecstasy by the United Nations, the White House, the U.S. Drug Enforcement Agency and the RCMP.